Clinical Trials on Breast Abscess in India
Total 182 results
-
Puma Biotechnology, Inc.CompletedNeoplasms | Breast NeoplasmsUnited States, Belgium, India, China, Russian Federation, Mexico, France
-
Novartis PharmaceuticalsCompletedPost Menopausal Breast CancerTaiwan, Malaysia, Turkey, Australia, Korea, Republic of, Thailand, Jordan, India, Vietnam, Morocco, Tunisia, Indonesia, South Africa
-
AstraZenecaDaiichi Sankyo Company, LimitedActive, not recruitingMetastatic Breast CancerUnited States, Italy, India, Taiwan, Germany, Korea, Republic of, Brazil, Poland, Russian Federation, Turkey, Spain, Australia, France, Canada, United Kingdom
-
Novartis PharmaceuticalsCompletedBreast CancerIndia, Malaysia, Saudi Arabia, Taiwan, Russian Federation, Lebanon, South Africa, Thailand, Jordan, Turkey, Egypt, Vietnam, Singapore
-
Bristol-Myers SquibbCompletedBreast CancerUnited States, India, Korea, Republic of, Taiwan, Spain, Germany, Austria, Italy, Peru, Russian Federation, Singapore, France, United Kingdom, Philippines, Argentina
-
EirGenix, Inc.CompletedBreast CancerTaiwan, India, Georgia, United States, Russian Federation, South Africa, Ukraine, Belarus, Chile, Colombia, Korea, Republic of
-
Eli Lilly and CompanyActive, not recruitingBreast CancerChina, India, South Africa, Brazil
-
AstraZenecaCompletedBreast CancerThailand, Korea, Republic of, Japan, Philippines, Taiwan, India
-
Tanvex BioPharma USA, Inc.CompletedBreast Cancer | Breast Neoplasms | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast CancerBelarus, Chile, Georgia, Hungary, India, Mexico, Peru, Philippines, Russian Federation, Ukraine
-
BayerCompletedBreast CancerSpain, Canada, Taiwan, United States, India, Netherlands, Poland, Germany, Argentina
-
CelltrionNippon Kayaku Co., Ltd.CompletedHER2-positive Carcinoma of BreastItaly, South Africa, Mexico, Japan, Taiwan, Russian Federation, Philippines, Hungary, Romania, Spain, Bosnia and Herzegovina, India, Peru, Ukraine, Latvia, Argentina, Georgia, Belarus, Chile, France, Poland, Portugal
-
Hoffmann-La RocheCompletedBreast CancerChina, Hong Kong, France, Spain, Italy, Turkey, Brazil, Egypt, Poland, India, Saudi Arabia
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerFrance, Canada, Israel, Italy, Argentina, Brazil, China, Croatia, Germany, Greece, Slovakia, Turkey, Saudi Arabia, Japan, India, Spain, United States, Czechia, Romania, United Kingdom, Morocco, South Africa, Vietnam, Russian Federation
-
Mylan Inc.Mylan GmbHCompletedBreast CancerSlovakia, Brazil, Chile, Georgia, Hungary, India, Latvia, Peru, Romania, Russian Federation, Serbia, South Africa, Thailand, Turkey, Ukraine
-
Sopherion TherapeuticsUnknownBreast CancerCanada, Spain, United States, United Kingdom, Poland, Germany, India, Italy, Argentina, Portugal, Russian Federation
-
Hoffmann-La RocheCompletedBreast CancerUnited States, United Kingdom, France, Italy, Spain, Turkey, Brazil, India
-
Pierre Fabre MedicamentCompletedBreast CancerFrance, Poland, Ukraine, United Kingdom, Taiwan, Spain, Belgium, Belarus, Mexico, Bulgaria, India, South Africa, Brazil, Russian Federation, Argentina, Hungary, Italy, Serbia, Switzerland, Czechia, Estonia
-
AstraZenecaTerminatedNeoplasms | Breast Cancer | Breast NeoplasmsBrazil, Czech Republic, Korea, Republic of, Mexico, Peru, Poland, Russian Federation, South Africa, United Kingdom, Philippines, Ukraine, Finland, Canada, Taiwan, India, Thailand, United States, Japan
-
AstraZenecaActive, not recruitingBreast CancerBelgium, Spain, Italy, United States, Brazil, Czechia, Russian Federation, Chile, Slovakia, Hungary, India, Ukraine, Venezuela, Colombia, Poland, Malta, Mexico
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerIsrael, United States, Australia, Korea, Republic of, Belgium, Argentina, Denmark, Finland, Italy, Portugal, Spain, Taiwan, Thailand, Japan, United Kingdom, Brazil, Canada, Colombia, Mexico, France, Costa Rica, Switzerland, Czechia, P... and more
-
Novartis PharmaceuticalsActive, not recruitingBreast CancerUnited States, South Africa, Austria, Hungary, Germany, Czechia, France, Russian Federation, Thailand, Belgium, Bulgaria, Lithuania, Jordan, Sweden, Finland, Peru, Colombia, Portugal, Canada, Brazil, India, Argentina, Costa Rica
-
SandozSandoz GmbHCompletedBreast Cancer | Chemotherapy-induced NeutropeniaSpain, United States, Argentina, Chile, India, Malaysia, Puerto Rico, Russian Federation
-
Hoffmann-La RocheRecruitingMetastatic Breast CancerUnited States, Korea, Republic of, Spain, Canada, Brazil, China, Singapore, India, Turkey, Argentina, Australia, Belgium, Finland, Hong Kong, South Africa, Italy, United Kingdom, France, Poland, Taiwan, Colombia, Germany, Mexico
-
PfizerCompletedBreast NeoplasmsUnited States, Canada, Czech Republic, Spain, Germany, Italy, India, United Kingdom
-
AstraZenecaDaiichi SankyoActive, not recruitingBreast Cancer | Breast Neoplasms | HER2-positive Early Breast CancerUnited States, Italy, Spain, Poland, Taiwan, Thailand, Canada, Germany, Korea, Republic of, Brazil, India, Japan, Peru, Philippines, China, Saudi Arabia, Russian Federation, Bulgaria
-
Hoffmann-La RocheCompletedBreast CancerUnited States, Korea, Republic of, Canada, United Kingdom, Australia, Belgium, Brazil, France, Slovenia, Spain, Taiwan, Japan, Italy, Argentina, India, Germany, Hungary, Russian Federation, Singapore, Ukraine, Costa Rica, Czechia, G... and more
-
Eli Lilly and CompanyAvailableMetastatic Breast CancerAustralia, Canada, Egypt, India, Italy, Korea, Republic of, Malaysia, Singapore, South Africa, Spain, Switzerland, Taiwan, Thailand, United Kingdom
-
AviGenicsCompletedBreast Cancer | NeutropeniaUnited States, India
-
Novartis PharmaceuticalsActive, not recruitingBreast CancerUnited States, Belgium, Italy, Spain, United Kingdom, Taiwan, Canada, Germany, Argentina, Israel, Korea, Republic of, Denmark, France, India, Chile, Netherlands, Singapore, Japan, Mexico
-
SanofiCancer International Research Group (CIRG)CompletedBreast NeoplasmsUnited States, France, Brazil, Romania, Russian Federation, Australia, Spain, Sweden, Turkey, India, Slovakia, Taiwan, Belgium, Czech Republic, Tunisia, Uruguay, Argentina, Croatia, Austria, Egypt, Greece, Hungary, Ireland, Israel, Italy, Mexic... and more
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited Kingdom, United States, Peru, Israel, Poland, Russian Federation, Korea, Republic of, Thailand, Pakistan, Hungary, India, Canada, France, Mexico, Malaysia, Singapore
-
Hoffmann-La RocheCompletedBreast CancerChina, United States, South Africa, Russian Federation, Thailand, Bosnia and Herzegovina, Czech Republic, India, Poland
-
PfizerCompletedMetastatic Breast CancerKorea, Republic of, Serbia, Argentina, Brazil, Japan, Peru, Turkey, United States, Slovakia, Mexico, Philippines, Poland, Romania, Hungary, India, Portugal, South Africa, Latvia, Thailand, Russian Federation, Ukraine, Chile, Czechia, ...
-
Novartis PharmaceuticalsActive, not recruitingTriple Negative Breast NeoplasmsFrance, Italy, Croatia, Taiwan, Australia, Argentina, Korea, Republic of, China, Israel, Russian Federation, Slovakia, Slovenia, United Kingdom, Germany, Mexico, Switzerland, Spain, Brazil, Hungary, Malaysia, South Africa, Austria, ... and more
-
ETOP IBCSG Partners FoundationBreast International GroupCompletedBreast CancerFrance, Spain, Switzerland, Australia, Belgium, Austria, Peru, Germany, Italy, Japan, New Zealand, Sweden, Denmark, India, United States, Chile, Russian Federation, United Kingdom, Hungary, South Africa
-
AmgenCompletedLocally Recurrent and Metastatic Breast CancerUnited States, United Kingdom, Denmark, Poland, Belgium, Hungary, Spain, Austria, France, Australia, Netherlands, Finland, India
-
SandozSandoz GmbHCompletedBreast Neoplasms | Chemotherapeutic Toxicity | Chemotherapy-induced Neutropenia | Neutropenic ComplicationsRussian Federation, Brazil, India, Mexico, Romania, Ukraine
-
Novartis PharmaceuticalsCompletedBreast CancerBelgium, Hungary, Spain, Argentina, Russian Federation, Sweden, Lebanon, Australia, Denmark, Ireland, United Kingdom, Thailand, Turkey, Peru, Brazil, Malaysia, India, United States
-
Novartis PharmaceuticalsCompletedAdvanced Metastatic Breast CancerCanada, Italy, Hungary, Taiwan, Turkey, Belgium, Germany, Spain, United States, Singapore, Australia, Korea, Republic of, Hong Kong, Thailand, Lebanon, Bulgaria, France, Russian Federation, Argentina, Brazil, Malaysia, Portugal, Col... and more
-
Hoffmann-La RocheCompletedBreast CancerFrance, Italy, Spain, Turkey, Brazil, India
-
AstraZenecaDaiichi SankyoRecruitingBreast CancerUnited States, Spain, United Kingdom, Korea, Republic of, Philippines, Canada, Germany, Italy, Poland, Belgium, Mexico, Japan, France, Brazil, Taiwan, Thailand, Hungary, Turkey, China, India, South Africa, Singapore, Argentina
-
AstraZenecaRecruitingLocally Advanced (Inoperable) or Metastatic Breast CancerSpain, Denmark, United States, Korea, Republic of, Germany, Belgium, Vietnam, United Kingdom, France, Japan, Canada, China, India, Malaysia, Taiwan, Thailand, Australia, Turkey, Argentina, Brazil, Poland, Sweden, Italy
-
AstraZenecaDaiichi SankyoActive, not recruitingBreast CancerBelgium, Canada, France, Italy, Spain, United Kingdom, Hungary, Poland, United States, Korea, Republic of, Brazil, India, Japan, Russian Federation, China, Taiwan, Netherlands, Germany, South Africa, Argentina
-
AstraZenecaRecruitingBreast Cancer, Early Breast CancerUnited States, Canada, United Kingdom, China, Argentina, Australia, Hungary, Netherlands, Korea, Republic of, France, Germany, Italy, Belgium, Bulgaria, India, Mexico, Spain, Vietnam, Colombia, Japan, Peru, Brazil, Malaysia, Taiwan, Tha... and more
-
AstraZenecaDaiichi SankyoRecruitingBreast CancerUnited States, Spain, China, Italy, Australia, United Kingdom, Korea, Republic of, Vietnam, Japan, Turkey, Brazil, Taiwan, Thailand, Canada, Argentina, India, France, Singapore, Mexico, Germany, Philippines, Poland, South Africa
-
AstraZenecaAustrian Breast and Colorectal Cancer Study Group (ABCSG)RecruitingBreast Cancer, Early Breast CancerUnited States, Spain, Italy, Korea, Republic of, Belgium, Poland, Portugal, United Kingdom, France, Canada, China, Germany, Japan, Mexico, Thailand, Hungary, Australia, Brazil, Colombia, Greece, Taiwan, Malaysia, Philippines, Austria, R... and more
-
Hoffmann-La RocheGenentech, Inc.CompletedBreast CancerItaly, Spain, Sweden, China, Hong Kong, Canada, South Africa, Ukraine, United States, United Kingdom, Russian Federation, Taiwan, Australia, Mexico, Turkey, Israel, Poland, Bulgaria, Germany, France, Netherlands, Norway, India, Hungary, Brazi... and more
-
Hoffmann-La RocheRecruitingLocally Advanced or Metastatic Breast CancerFrance, Belgium, United States, Korea, Republic of, Taiwan, Brazil, China, Italy, Argentina, Jordan, Mexico, Germany, Portugal, Spain, Thailand, United Kingdom, Kenya, Turkey, Hungary, Colombia, India, Oman, Saudi Arabia, Poland, Uganda, United... and more
-
Celcuity, Inc.RecruitingBreast CancerKorea, Republic of, United States, Belgium, United Kingdom, Taiwan, France, Italy, Australia, Singapore, Argentina, Canada, India, Mexico, Czechia, Spain, Austria, Bulgaria, Germany, Hungary, Poland, Brazil, Greece, Romania
-
AstraZenecaDaiichi Sankyo Company, Limited 3-5-1 Nihonbashihoncho, Chuo-ku, TokyoActive, not recruitingAdvanced or Metastatic Breast CancerUnited States, Belgium, Canada, Denmark, France, Italy, Spain, Hungary, Poland, Taiwan, Russian Federation, Germany, Korea, Republic of, Brazil, Japan, Mexico, United Kingdom, China, Israel, Austria, Australia, Saudi Arabia, Netherl... and more